pISSN 1226-6051
eISSN 2508-786X
eISSN 2508-786X
Drug characteristics of included prescriptions
| Drug Characteristics | FDC | FC | p-value |
|---|---|---|---|
| Prescriptions (%) | Prescriptions (%) | ||
| Total | 252,797 (100.0) | 515,666 (100) | |
| Number of active ingredients in combination | <0.001 | ||
| 2 | 250,628 (99.1) | 482,201 (93.5) | |
| 3 | 2,169 (0.9) | 33,465 (6.5) | |
| Type of combination | |||
| Statin/lipid lowering agents |
185,260 (73.3) | 10,223 (2) | <0.001 |
| Rosuvastatin, ezetimibe | 137,071 (54.2) | 566 (0.1) | |
| Simvastatin, ezetimibe | 25,692 (10.2) | 37 (0) | |
| Atorvastatin, ezetimibe | 18,074 (7.2) | 689 (0.1) | |
| Rosuvastatin, omega-3-acid ethyl ester | 3,071 (1.2) | 9,404 (1.8) | |
| Simvastatin, fenofibrate | 1,355 (0.5) | 607 (0.1) | |
| Statin/antihypertensives |
67,219 (26.6) | 352,248 (68.3) | <0.001 |
| Atorvastatin, amlodipine | 24,133 (9.6) | 170,769 (33.1) | |
| Rosuvastatin, telmisartan | 16,241 (6.4) | 31,396 (6.1) | |
| Atorvastatin, irbesartan | 8,790 (3.5) | 7,653 (1.5) | |
| Rosuvastatin, olmesartan | 5,839 (2.3) | 24,641 (4.8) | |
| Pitavastatin, valsartan | 3,518 (1.4) | 7,287 (1.4) | |
| Rosuvastatin, valsartan | 2,518 (1) | 45,507 (8.8) | |
| Rosuvastatin, candesartan | 2,348 (0.9) | 15,545 (3) | |
| Rosuvastatin, losartan, amlodipine | 1,579 (0.6) | 12,467 (2.4) | |
| Rosuvastatin, fimasartan | 1,462 (0.6) | 9,956 (1.9) | |
| Rosuvastatin, telmisartan, amlodipine | 590 (0.2) | 21,015 (4.1) | |
| Rosuvastatin, amlodipine | 229 (0.1) | 111,500 (21.6) | |
| Statin/antidiabetics |
444 (0.2) | 253,622 (49.2) | <0.001 |
| Rosuvastatin, gemigliptin | 312 (0.1) | 13,457 (2.6) | |
| Rosuvastatin, metformin | 78 (0) | 107,464 (20.8) | |
| Atorvastatin, metformin | 54 (0) | 155,945 (30.2) | |
* The sum of subgroups may exceed the total because of duplicates
FDC, fixed-dose combination; FC, free combination